FI962993A - Transdermal device containing 14alpha, 17alpha-ethanoestra-1,3,5 (10) -triene-3,17beta-diol - Google Patents

Transdermal device containing 14alpha, 17alpha-ethanoestra-1,3,5 (10) -triene-3,17beta-diol Download PDF

Info

Publication number
FI962993A
FI962993A FI962993A FI962993A FI962993A FI 962993 A FI962993 A FI 962993A FI 962993 A FI962993 A FI 962993A FI 962993 A FI962993 A FI 962993A FI 962993 A FI962993 A FI 962993A
Authority
FI
Finland
Prior art keywords
ethanoestra
14alpha
17alpha
17beta
triene
Prior art date
Application number
FI962993A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI962993A0 (en
Inventor
Clemens Guenther
Ralph Lipp
Ulrich Taeuber
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI962993A0 publication Critical patent/FI962993A0/en
Publication of FI962993A publication Critical patent/FI962993A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI962993A 1994-01-27 1996-07-26 Transdermal device containing 14alpha, 17alpha-ethanoestra-1,3,5 (10) -triene-3,17beta-diol FI962993A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1994/000213 WO1995020392A1 (en) 1994-01-27 1994-01-27 AGENT, INTENDED FOR TRANSDERMAL ADMINISTRATION, CONTAINING 14α,17α-ETHANOESTRA-1,3,5(10)-TRIENE-3,17β-DIOL

Publications (2)

Publication Number Publication Date
FI962993A0 FI962993A0 (en) 1996-07-26
FI962993A true FI962993A (en) 1996-07-26

Family

ID=8165820

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962993A FI962993A (en) 1994-01-27 1996-07-26 Transdermal device containing 14alpha, 17alpha-ethanoestra-1,3,5 (10) -triene-3,17beta-diol

Country Status (6)

Country Link
EP (1) EP0741572A1 (en)
JP (1) JPH09510697A (en)
AU (1) AU5971294A (en)
FI (1) FI962993A (en)
NO (1) NO963128L (en)
WO (1) WO1995020392A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19526864A1 (en) * 1995-07-22 1997-01-23 Labtec Gmbh Hormone patches
AU2002340676B2 (en) * 2001-11-09 2008-12-11 Valeant Pharmaceuticals International, Inc. Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
CH674618A5 (en) * 1987-04-02 1990-06-29 Ciba Geigy Ag
ES2081823T3 (en) * 1988-10-27 1996-03-16 Schering Ag AGENT FOR TRANSDERMIC APPLICATION, CONTAINING GESTODEN.
DE3838779A1 (en) * 1988-11-11 1990-05-17 Schering Ag 14 (ALPHA), 17 (ALPHA) ETHANO ESTRATRIENE
DE4227989A1 (en) * 1992-08-21 1994-06-09 Schering Ag Agent for transdermal application containing 3-keto-desogestrel

Also Published As

Publication number Publication date
JPH09510697A (en) 1997-10-28
FI962993A0 (en) 1996-07-26
WO1995020392A1 (en) 1995-08-03
AU5971294A (en) 1995-08-15
NO963128D0 (en) 1996-07-26
EP0741572A1 (en) 1996-11-13
NO963128L (en) 1996-07-26

Similar Documents

Publication Publication Date Title
BR9508707A (en) Stabilizing device
EP0683401A3 (en) Locating device.
MA24062A1 (en) HETEROATOME COMPRISING CYCLOPENTANO-PYRIDILE OXAZOLIDINONES
GB2298498B (en) Blade holding device
NO951513D0 (en) Control device
DE59503468D1 (en) STAMP DEVICE
KR960003119U (en) Device spacing control
BR9501850A (en) Locating device
DE59600062D1 (en) Mixing device
DE69504227D1 (en) Holding device
DE59607626D1 (en) Mixing device
NO305341B1 (en) Electro-fishing device
NO970620D0 (en) Vacuum-planting device
DE69521774D1 (en) Radiotelephone device
NL1001127C1 (en) Fastening device.
DE69500707D1 (en) Holding device
DE59405782D1 (en) Device for operating stepper motors
NL1000719C2 (en) Printing device.
DE69612672D1 (en) MIXING DEVICE
FI962993A (en) Transdermal device containing 14alpha, 17alpha-ethanoestra-1,3,5 (10) -triene-3,17beta-diol
DE69510880D1 (en) One-lever control device
ITTO940664A0 (en) DECELATOR DEVICE FOR POSTAL OBJECTS
DE69508843D1 (en) Packaging device
NO950149D0 (en) composting device
DE59503772D1 (en) Fumigation device

Legal Events

Date Code Title Description
FD Application lapsed